Redeye initiates coverage of Boreo, an emerging serial acquirer primarily focusing on Finland and the Baltics. We judge comparatively little M&A competition in these geographies bodes well for acquired growth. However, financial M&A capacity will likely constitute a limiting factor in coming years. As recent years’ organic headwinds disappear, we judge that Boreo should realise solid operating leverage, boosting profit expansion.

Read more and download the Research Report.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/